SEC Form 4 · accession 0001209191-19-007747
PUMA BIOTECHNOLOGY, INC. · PBYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles R Eyler
Officer — SEE REMARKS
Period of report
Feb 4, 2019
Accepted (ET)
Feb 6, 2019 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Feb 4, 2019 | S | 87 | $27.6404 | D | 31,957 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
Remarks
Title of Reporting Person: Senior Vice President, Finance and Administration and Treasurer